'Covid Shield+'—By Edelweiss Tokio Life Insurance

Current Context: The Edelweiss Tokio Life Insurance launched the insurance products called 'Covid Shield+'.

• The 'Covid Shield+' is India’s first individual Covid-19 life insurance product.
• It provides financial protection against the impact of COVID-19.
• It is the new niche product category in the insurance industry, which fulfil the increased protection need of people, which is vital during this pandemic state.
• It is a cost-effective product which requires no medical test and also provides immediate support to the policyholder.
• The 'Covid Shield+' has a tenure of 1 year with its premium rates starting from Rs 5,329.
• It offers a critical illness benefit of minimum Rs 10 lakh post-24-hour ICU or HDU hospitalization owing to Covid-19.
• Also if diagnosed with COVID-19, the product also triggers minimum enhanced term cover worth Rs25 lakh sum assured.
• People belonging to the age group of 18 to 65 years can opt for this insurance product. 
• Static Part: 
• HQ of Edelweiss Tokio Life Insurance: Mumbai
• MD and CEO of Edelweiss Tokio Life Insurance: Sumit Rai

Question: 

Q.1 Which organisation launched ‘Covid Shield+' which is India’s first individual Covid-19 life insurance product?
a. Aegon Life Insurance
b. SBI Life Insurance
c. Edelweiss Tokio Life Insurance 

d. HDFC Life Insurance